位置:首页 > 蛋白库 > GPCP1_MOUSE
GPCP1_MOUSE
ID   GPCP1_MOUSE             Reviewed;         675 AA.
AC   Q8C0L9; A2AMD5; Q3TLV6; Q80TD5; Q8BKJ7; Q8BKW7; Q8CFW2; Q9D759;
DT   03-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   03-AUG-2022, entry version 149.
DE   RecName: Full=Glycerophosphocholine phosphodiesterase GPCPD1;
DE            EC=3.1.4.2;
DE   AltName: Full=Glycerophosphodiester phosphodiesterase 5;
DE   AltName: Full=Preimplantation protein 4;
GN   Name=Gpcpd1; Synonyms=Gde5, Kiaa1434, Prei4;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Brain;
RX   PubMed=12693553; DOI=10.1093/dnares/10.1.35;
RA   Okazaki N., Kikuno R., Ohara R., Inamoto S., Aizawa H., Yuasa S.,
RA   Nakajima D., Nagase T., Ohara O., Koga H.;
RT   "Prediction of the coding sequences of mouse homologues of KIAA gene: II.
RT   The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs
RT   identified by screening of terminal sequences of cDNA clones randomly
RT   sampled from size-fractionated libraries.";
RL   DNA Res. 10:35-48(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   STRAIN=C57BL/6J;
RC   TISSUE=Embryo, Embryonic spinal ganglion, Head, Mammary gland, and Tongue;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-611, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=18034455; DOI=10.1021/pr0701254;
RA   Ballif B.A., Carey G.R., Sunyaev S.R., Gygi S.P.;
RT   "Large-scale identification and evolution indexing of tyrosine
RT   phosphorylation sites from murine brain.";
RL   J. Proteome Res. 7:311-318(2008).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-427, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Liver, Lung, Spleen, and
RC   Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, SUBCELLULAR
RP   LOCATION, TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=20576599; DOI=10.1074/jbc.m110.106708;
RA   Okazaki Y., Ohshima N., Yoshizawa I., Kamei Y., Mariggio S., Okamoto K.,
RA   Maeda M., Nogusa Y., Fujioka Y., Izumi T., Ogawa Y., Shiro Y., Wada M.,
RA   Kato N., Corda D., Yanaka N.;
RT   "A novel glycerophosphodiester phosphodiesterase, GDE5, controls skeletal
RT   muscle development via a non-enzymatic mechanism.";
RL   J. Biol. Chem. 285:27652-27663(2010).
CC   -!- FUNCTION: May be involved in the negative regulation of skeletal muscle
CC       differentiation, independently of its glycerophosphocholine
CC       phosphodiesterase activity. {ECO:0000269|PubMed:20576599}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + sn-glycerol 3-phosphocholine = choline + H(+) + sn-
CC         glycerol 3-phosphate; Xref=Rhea:RHEA:16061, ChEBI:CHEBI:15354,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:16870,
CC         ChEBI:CHEBI:57597; EC=3.1.4.2;
CC         Evidence={ECO:0000269|PubMed:20576599};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         Vmax=2.0 umol/min/mg enzyme with glycerophosphocholine as substrate
CC         {ECO:0000269|PubMed:20576599};
CC         Vmax=0.34 umol/min/mg enzyme with glycerophosphoethanolamine as
CC         substrate {ECO:0000269|PubMed:20576599};
CC         Note=No significant reactions when glycerophosphoglycerol,
CC         glycerophosphoinositol and glycerophosphoserine are used as
CC         substrates.;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:20576599}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8C0L9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8C0L9-2; Sequence=VSP_020820;
CC       Name=3;
CC         IsoId=Q8C0L9-3; Sequence=VSP_020819;
CC   -!- TISSUE SPECIFICITY: Widely expressed with highest levels in skeletal
CC       muscle and heart. {ECO:0000269|PubMed:20576599}.
CC   -!- DEVELOPMENTAL STAGE: Down-regulated in skeletal muscles atrophies,
CC       including atrophies linked to aging and denervation.
CC       {ECO:0000269|PubMed:20576599}.
CC   -!- SIMILARITY: Belongs to the glycerophosphoryl diester phosphodiesterase
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB26361.2; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAC33775.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAC34739.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAC65792.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK122510; BAC65792.1; ALT_INIT; mRNA.
DR   EMBL; AK009563; BAB26361.2; ALT_INIT; mRNA.
DR   EMBL; AK030645; BAC27063.1; -; mRNA.
DR   EMBL; AK049491; BAC33775.1; ALT_INIT; mRNA.
DR   EMBL; AK051728; BAC34739.1; ALT_INIT; mRNA.
DR   EMBL; AK166293; BAE38686.1; -; mRNA.
DR   EMBL; AL807386; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC033408; AAH33408.1; -; mRNA.
DR   CCDS; CCDS38246.1; -. [Q8C0L9-1]
DR   CCDS; CCDS71151.1; -. [Q8C0L9-2]
DR   RefSeq; NP_001277979.1; NM_001291050.1. [Q8C0L9-2]
DR   RefSeq; NP_001277980.1; NM_001291051.1. [Q8C0L9-2]
DR   RefSeq; NP_001277981.1; NM_001291052.1. [Q8C0L9-2]
DR   RefSeq; NP_081372.1; NM_027096.2. [Q8C0L9-2]
DR   RefSeq; NP_083078.3; NM_028802.3. [Q8C0L9-1]
DR   RefSeq; XP_011238111.1; XM_011239809.2.
DR   RefSeq; XP_017174784.1; XM_017319295.1.
DR   AlphaFoldDB; Q8C0L9; -.
DR   SMR; Q8C0L9; -.
DR   STRING; 10090.ENSMUSP00000105769; -.
DR   CAZy; CBM20; Carbohydrate-Binding Module Family 20.
DR   iPTMnet; Q8C0L9; -.
DR   PhosphoSitePlus; Q8C0L9; -.
DR   EPD; Q8C0L9; -.
DR   jPOST; Q8C0L9; -.
DR   MaxQB; Q8C0L9; -.
DR   PaxDb; Q8C0L9; -.
DR   PeptideAtlas; Q8C0L9; -.
DR   PRIDE; Q8C0L9; -.
DR   ProteomicsDB; 271434; -. [Q8C0L9-1]
DR   ProteomicsDB; 271435; -. [Q8C0L9-2]
DR   ProteomicsDB; 271436; -. [Q8C0L9-3]
DR   Antibodypedia; 23917; 27 antibodies from 10 providers.
DR   DNASU; 74182; -.
DR   Ensembl; ENSMUST00000060955; ENSMUSP00000062221; ENSMUSG00000027346. [Q8C0L9-1]
DR   Ensembl; ENSMUST00000110136; ENSMUSP00000105763; ENSMUSG00000027346. [Q8C0L9-2]
DR   Ensembl; ENSMUST00000110142; ENSMUSP00000105769; ENSMUSG00000027346. [Q8C0L9-1]
DR   GeneID; 74182; -.
DR   KEGG; mmu:74182; -.
DR   UCSC; uc008mmv.2; mouse. [Q8C0L9-1]
DR   CTD; 56261; -.
DR   MGI; MGI:104898; Gpcpd1.
DR   VEuPathDB; HostDB:ENSMUSG00000027346; -.
DR   eggNOG; KOG2421; Eukaryota.
DR   GeneTree; ENSGT00440000033970; -.
DR   HOGENOM; CLU_013007_2_0_1; -.
DR   InParanoid; Q8C0L9; -.
DR   OMA; YHTAEGL; -.
DR   OrthoDB; 687958at2759; -.
DR   PhylomeDB; Q8C0L9; -.
DR   TreeFam; TF314722; -.
DR   BioGRID-ORCS; 74182; 1 hit in 73 CRISPR screens.
DR   ChiTaRS; Gpcpd1; mouse.
DR   PRO; PR:Q8C0L9; -.
DR   Proteomes; UP000000589; Chromosome 2.
DR   RNAct; Q8C0L9; protein.
DR   Bgee; ENSMUSG00000027346; Expressed in triceps brachii and 256 other tissues.
DR   ExpressionAtlas; Q8C0L9; baseline and differential.
DR   Genevisible; Q8C0L9; MM.
DR   GO; GO:0005737; C:cytoplasm; IDA:MGI.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0047389; F:glycerophosphocholine phosphodiesterase activity; IDA:MGI.
DR   GO; GO:0008889; F:glycerophosphodiester phosphodiesterase activity; TAS:Reactome.
DR   GO; GO:2001070; F:starch binding; IEA:InterPro.
DR   GO; GO:0046475; P:glycerophospholipid catabolic process; IBA:GO_Central.
DR   GO; GO:0007519; P:skeletal muscle tissue development; IMP:MGI.
DR   CDD; cd05814; CBM20_Prei4; 1.
DR   Gene3D; 2.60.40.10; -; 1.
DR   Gene3D; 3.20.20.190; -; 1.
DR   InterPro; IPR013784; Carb-bd-like_fold.
DR   InterPro; IPR034839; CBM20_GPCPD1.
DR   InterPro; IPR002044; CBM_fam20.
DR   InterPro; IPR033506; Gde1.
DR   InterPro; IPR030395; GP_PDE_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR017946; PLC-like_Pdiesterase_TIM-brl.
DR   PANTHER; PTHR22958:SF1; PTHR22958:SF1; 1.
DR   Pfam; PF00686; CBM_20; 1.
DR   Pfam; PF03009; GDPD; 1.
DR   SMART; SM01065; CBM_2; 1.
DR   SUPFAM; SSF49452; SSF49452; 1.
DR   SUPFAM; SSF51695; SSF51695; 1.
DR   PROSITE; PS51166; CBM20; 1.
DR   PROSITE; PS51704; GP_PDE; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cytoplasm; Hydrolase; Phosphoprotein;
KW   Reference proteome.
FT   CHAIN           1..675
FT                   /note="Glycerophosphocholine phosphodiesterase GPCPD1"
FT                   /id="PRO_0000251947"
FT   DOMAIN          1..115
FT                   /note="CBM20"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00594"
FT   DOMAIN          321..621
FT                   /note="GP-PDE"
FT   BINDING         70
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000255"
FT   BINDING         88..89
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         178
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NPB8"
FT   MOD_RES         427
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         611
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:18034455"
FT   VAR_SEQ         1..445
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:12693553"
FT                   /id="VSP_020819"
FT   VAR_SEQ         1..184
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_020820"
FT   CONFLICT        289
FT                   /note="G -> D (in Ref. 2; BAE38686)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        460
FT                   /note="E -> Q (in Ref. 2; BAC33775)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        494..495
FT                   /note="LE -> SQ (in Ref. 2; BAC33775)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        499
FT                   /note="K -> N (in Ref. 2; BAC33775)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        559
FT                   /note="L -> S (in Ref. 2; BAB26361)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        602
FT                   /note="K -> E (in Ref. 2; BAB26361)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   675 AA;  76579 MW;  7ABF9EE48CF39B47 CRC64;
     MTPSQVTFEI RGTLLPGEVF AICGSCDALG NWNPQNAVAL INENETGDSV LWKAVIALNR
     GVSVKYRYFR GCFLEPKTIG GPCQVIVHKW ETHLQPRSIT PLESEIIIDD GQFGIHNGVE
     TLDSGWLTCQ TEIRLRLHFS EKPPVSISKK KFKKSRFRVK LTLEGLEEDE DDDDDKVSPT
     VLHKMSNSLE ISLISDNEFK CRHSQPECGY GLQPDRWTEY SIQTMEPDNL ELIFDFFEED
     LSEHVVQGDV LPGHVGTACL LSSTIAESGR SAGILTLPIM SRNSRKTIGK VRVDFIIIKP
     LPGYSCSMQS SFSKYWKPRI PLDVGHRGAG NSTTTAKLAK VQENTIASLR NAASHGAAFV
     EFDVHLSKDF VPVVYHDLTC CLTMKRKYEA DPVELFEIPV KELTFDQLQL LKLSHVTALK
     TKDRKQSLYE EENFFSENQP FPSLKMVLES LPENVGFNIE IKWICQHRDG VWDGNLSTYF
     DMNVFLDIIL KTVLENSGKR RIVFSSFDAD ICTMVRQKQN KYPILFLTQG KSDIYPELMD
     LRSRTTPIAM SFAQFENILG INAHTEDLLR NPSYVQEAKA KGLVIFCWGD DTNDPENRRK
     LKEFGVNGLI YDRIYDWMPE QPNIFQVEQL ERLKQELPEL KNCLCPTVSH FIPSSFCVEP
     DIHVDANGID SVENA
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024